Haemostasis is the vital physiological process that stops bleeding when a blood vessel is injured, while keeping blood flowing smoothly everywhere else in the body. Without this precise balance, minor scrapes could lead to fatal haemorrhage, or tiny clots could block critical vessels.
The process unfolds in three rapid, overlapping stages:
In midwifery practice, understanding haemostasis is essential for managing postpartum haemorrhage and recognizing why a mother's clotting system might fail after delivery.
When a blood vessel wall tears, smooth muscle in the wall contracts instantly. This vascular spasm reduces blood loss immediately, buying time for the slower cellular and chemical phases to kick in. The response is triggered by direct injury to the muscle, pain receptors, and chemicals released by endothelial cells.
Shortly after, circulating platelets encounter exposed collagen fibres in the broken vessel wall. They undergo a dramatic change: they become sticky, swell up, and sprout long projections. As they clump together, they release chemical messengers like adenosine diphosphate (ADP) and thromboxane A2, which recruit even more platelets to the site. This rapid aggregation forms a loose platelet plug that temporarily patches the hole.
While the platelet plug provides a quick patch, it is fragile and can easily wash away under high blood pressure. The coagulation cascade transforms liquid blood into a solid gel by converting soluble fibrinogen into insoluble fibrin strands that reinforce the plug.
The cascade is a series of enzymatic reactions where inactive plasma proteins, known as clotting factors, activate one another in a specific sequence. Most of these factors are produced by the liver and circulate in an inactive state until injury occurs. Roman numerals (from I to XIII) are assigned to these factors in the order of their discovery, not the order in which they react in the body.
The coagulation cascade can be triggered by two separate routes that eventually merge: the intrinsic pathway and the extrinsic pathway.
| Feature | Intrinsic Pathway | Extrinsic Pathway |
|---|---|---|
| Trigger | Trauma inside the vascular system or exposure to collagen | Trauma to tissue outside the blood vessel |
| Speed | Slower (takes several minutes) | Faster (takes seconds) |
| Starting Factor | Factor XII (Hageman factor) | Tissue Factor (Factor III) |
Both pathways ultimately converge by activating Factor X, proving that the body uses multiple checks and balances to ensure bleeding stops efficiently.
Once either the intrinsic or extrinsic pathway activates Factor X, the process enters the common pathway.
Activated Factor X combines with Factor V, calcium ions, and platelet phospholipids to form prothrombin activator. This enzyme converts the plasma protein prothrombin (Factor II) into the active enzyme thrombin. Thrombin then performs the critical final step: it cleaves soluble fibrinogen (Factor I) into long, sticky strands of fibrin.
Stabilized by Factor XIII, these fibrin strands weave through and around the platelet plug, trapping blood cells to create a tough, durable blood clot.
Clotting must remain localized to the injury site; otherwise, runaway clots could block healthy blood vessels and cause strokes or pulmonary emboli. The body uses natural anticoagulants, such as antithrombin III and protein C, to deactivate excess clotting factors and keep the cascade in check.
Once the blood vessel wall heals, the clot is no longer needed. Fibrinolysis is the gradual process of dissolving the clot. Plasminogen, trapped inside the clot, is converted into active plasmin by tissue plasminogen activator (tPA). Plasmin steadily chops up the fibrin mesh into small pieces, which are cleared away by macrophages, restoring normal blood flow.
Defects in any part of the haemostatic mechanism can lead to severe clinical problems. Genetic disorders like haemophilia involve a deficiency in specific clotting factors (such as Factor VIII or IX), leading to prolonged bleeding after minor injuries. Conversely, conditions that cause sluggish blood flow or endothelial damage can trigger inappropriate clot formation, known as thrombosis.
In midwifery, conditions like Disseminated Intravascular Coagulation (DIC) represent a life-threatening emergency where widespread clotting consumes all available platelets and factors, paradoxically resulting in severe, uncontrolled haemorrhage from every site.